Brief: Oncternal Therapeutics Provides Business Update And Announces Fourth Quarter And Full Year 2021 Financial Results
10/03/2022 21:05
March 10 (Reuters) - Oncternal Therapeutics Inc ONCT.O :
* ONCTERNAL THERAPEUTICS PROVIDES BUSINESS UPDATE
AND ANNOUNCES
FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
* ONCTERNAL THERAPEUTICS INC - GRANT REVENUE WAS $0.6
MILLION FOR
Q4 ENDED DECEMBER 31, 2021
* ONCTERNAL THERAPEUTICS INC - NET LOSS FOR Q4 WAS $8.1
MILLION,
OR A LOSS OF $0.16 PER SHARE, BASIC AND DILUTED
* ONCTERNAL THERAPEUTICS INC - BELIEVE FUNDS WILL BE
SUFFICIENT TO
FUND OUR OPERATIONS INTO MID-2023
Source text for Eikon: ID:nGNX5rH0r2
Further company coverage: ONCT.O
Recent news on Oncternal Therapeutics
See all newsOncternal Therapeutics Inc expected to post a loss of $3.19 a share - Earnings Preview
Brief: Oncternal Therapeutics Workforce Reduction Of About 10 Employees
U.S. STOCKS ON THE MOVE-Unity Software, Viking Holdings, Adobe
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery
Oncternal hits record low on plans to scrap studies, explore strategic alternatives;